Innovent Biologics Announces Board Reshuffle
Company Announcements

Innovent Biologics Announces Board Reshuffle

Innovent Biologics (HK:1801) has released an update.

Innovent Biologics, a biopharmaceutical company, has announced changes to its board committees, effective August 30, 2024. Dr. De-Chao Michael Yu has transitioned from chairman to member of the Nomination Committee, stepping down from the Remuneration Committee. Mr. Shuyun Chen moves from member to chairman of the Nomination Committee and joins the Audit Committee.

For further insights into HK:1801 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskInnovent Biologics Ends Proposed Subscription Agreement
TipRanks HongKong Auto-Generated NewsdeskInnovent Biologics Reports Strong Revenue Growth in Q3 2024
TheFlyInnovent Biologics says picankibart phase 2 study met primary endpoint
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App